Cargando…
Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials
The identification of new surrogate endpoints for advanced colorectal cancer is becoming crucial and, along with drug development, it represents a research field increasingly studied. Although overall survival (OS) remains the strongest trial endpoint available, it requires larger sample size and lo...
Autores principales: | Aprile, Giuseppe, Fontanella, Caterina, Bonotto, Marta, Rihawi, Karim, Lutrino, Stefania Eufemia, Ferrari, Laura, Casagrande, Mariaelena, Ongaro, Elena, Berretta, Massimiliano, Avallone, Antonio, Rosati, Gerardo, Giuliani, Francesco, Fasola, Gianpiero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745687/ https://www.ncbi.nlm.nih.gov/pubmed/26308250 |
Ejemplares similares
-
HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
por: Fanotto, Valentina, et al.
Publicado: (2016) -
HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series
por: Aprile, Giuseppe, et al.
Publicado: (2013) -
Ramucirumab: preclinical research and clinical development
por: Aprile, Giuseppe, et al.
Publicado: (2014) -
Molecular classifications of gastric cancers: Novel insights and possible future applications
por: Garattini, Silvio Ken, et al.
Publicado: (2017) -
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
por: Aprile, Giuseppe, et al.
Publicado: (2015)